PT Sarana Meditama Metropolitan Tbk (SAME.JK)
IDR 290.0
(-1.36%)
IDR 290.0
(-1.36%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 434.04 Billion IDR | -8.99% |
| 2022 | 476.93 Billion IDR | -12.1% |
| 2021 | 542.56 Billion IDR | 133.83% |
| 2020 | 232.03 Billion IDR | 9.2% |
| 2019 | 212.48 Billion IDR | -50.01% |
| 2018 | 425.05 Billion IDR | 19.18% |
| 2017 | 356.63 Billion IDR | 20.58% |
| 2016 | 295.76 Billion IDR | 16.57% |
| 2015 | 253.71 Billion IDR | 24.46% |
| 2014 | 203.84 Billion IDR | 24.08% |
| 2013 | 164.28 Billion IDR | 36.19% |
| 2012 | 120.63 Billion IDR | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q2 | 100.03 Billion IDR | -31.72% |
| 2024 Q1 | 146.5 Billion IDR | 40.42% |
| 2024 Q3 | 110.72 Billion IDR | 10.69% |
| 2023 Q1 | 130.33 Billion IDR | -1.15% |
| 2023 Q4 | 104.33 Billion IDR | -29.69% |
| 2023 Q3 | 148.4 Billion IDR | 13.13% |
| 2023 Q2 | 131.17 Billion IDR | 0.65% |
| 2023 FY | 434.04 Billion IDR | -8.99% |
| 2022 Q3 | 139.68 Billion IDR | 72.22% |
| 2022 Q4 | 131.85 Billion IDR | -5.6% |
| 2022 FY | 476.93 Billion IDR | -12.1% |
| 2022 Q1 | 124.28 Billion IDR | 21.68% |
| 2022 Q2 | 81.1 Billion IDR | -34.74% |
| 2021 Q2 | 122.48 Billion IDR | 3.34% |
| 2021 Q3 | 199.4 Billion IDR | 62.79% |
| 2021 Q4 | 102.14 Billion IDR | -48.78% |
| 2021 FY | 542.56 Billion IDR | 133.83% |
| 2021 Q1 | 118.53 Billion IDR | 34.79% |
| 2020 FY | 232.03 Billion IDR | 9.2% |
| 2020 Q1 | 61.43 Billion IDR | 16.17% |
| 2020 Q2 | 26.04 Billion IDR | -57.61% |
| 2020 Q3 | 56.62 Billion IDR | 117.43% |
| 2020 Q4 | 87.93 Billion IDR | 55.3% |
| 2019 Q1 | 121.69 Billion IDR | 12.93% |
| 2019 FY | 212.48 Billion IDR | -50.01% |
| 2019 Q4 | 52.88 Billion IDR | 174.91% |
| 2019 Q3 | -70.59 Billion IDR | -165.06% |
| 2019 Q2 | 108.5 Billion IDR | -10.84% |
| 2018 Q3 | 106.15 Billion IDR | -2.6% |
| 2018 FY | 425.05 Billion IDR | 19.18% |
| 2018 Q1 | 102.15 Billion IDR | 9.63% |
| 2018 Q2 | 108.98 Billion IDR | 6.69% |
| 2018 Q4 | 107.76 Billion IDR | 1.52% |
| 2017 FY | 356.63 Billion IDR | 20.58% |
| 2017 Q1 | 83.64 Billion IDR | -2.92% |
| 2017 Q2 | 87.08 Billion IDR | 4.1% |
| 2017 Q3 | 92.73 Billion IDR | 6.49% |
| 2017 Q4 | 93.17 Billion IDR | 0.47% |
| 2016 Q1 | 70.78 Billion IDR | 4.84% |
| 2016 FY | 295.76 Billion IDR | 16.57% |
| 2016 Q4 | 86.16 Billion IDR | 25.81% |
| 2016 Q3 | 68.49 Billion IDR | -2.6% |
| 2016 Q2 | 70.32 Billion IDR | -0.65% |
| 2015 Q2 | 65.8 Billion IDR | 12.8% |
| 2015 Q1 | 58.33 Billion IDR | 2.03% |
| 2015 FY | 253.71 Billion IDR | 24.46% |
| 2015 Q4 | 67.51 Billion IDR | 8.81% |
| 2015 Q3 | 62.05 Billion IDR | -5.7% |
| 2014 Q2 | 52.09 Billion IDR | 19.85% |
| 2014 FY | 203.84 Billion IDR | 24.08% |
| 2014 Q4 | 57.17 Billion IDR | 11.87% |
| 2014 Q1 | 43.46 Billion IDR | 0.38% |
| 2014 Q3 | 51.1 Billion IDR | -1.9% |
| 2013 Q1 | 33.56 Billion IDR | 30.86% |
| 2013 Q3 | 43.18 Billion IDR | 1.41% |
| 2013 Q4 | 43.3 Billion IDR | 0.27% |
| 2013 FY | 164.28 Billion IDR | 36.19% |
| 2013 Q2 | 42.59 Billion IDR | 26.91% |
| 2012 FY | 120.63 Billion IDR | 0.0% |
| 2012 Q4 | 25.64 Billion IDR | -16.06% |
| 2012 Q3 | 30.55 Billion IDR | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| PT Bundamedik Tbk | 582.25 Billion IDR | 25.455% |
| PT Metro Healthcare Indonesia Tbk | 89.65 Billion IDR | -384.129% |
| PT Medikaloka Hermina Tbk | 1824.23 Billion IDR | 76.207% |
| PT Mitra Keluarga Karyasehat Tbk | 1968.05 Billion IDR | 77.946% |
| PT Murni Sadar Tbk | 167.6 Billion IDR | -158.968% |
| PT Famon Awal Bros Sedaya Tbk | 515.99 Billion IDR | 15.882% |
| PT Royal Prima Tbk | 75.23 Billion IDR | -476.905% |
| PT Kedoya Adyaraya Tbk | 128.11 Billion IDR | -238.798% |
| PT Siloam International Hospitals Tbk | 3644.9 Billion IDR | 88.092% |
| PT Sejahteraraya Anugrahjaya Tbk | 718.02 Billion IDR | 39.55% |